ro.glp 1 RO LAUNCHES ELI LILLY'S KWIKPEN®, OFFERING PATIENTS A MORE CONVENIENT WAY TO TAKE ZEPBOUND® Ro launches the GLP-1 Supply

Randomized trials testing GLP-1 drugs for prevention and treatment of addiction are needed.I wrote about the concept of "drug noise" in @statnews statnews.com/2026/03/04/glp And the implications in @ConversationUS theconversation.com/glp-1-drugs-maGrateful to my co-authors Miao Cai, Taeyoung Choi, and Yan Xie

Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

Circulation 143 , 770779 (2021)

Berberine research and mechanisms Berberine stands out as the best-researched natural compound for metabolic effects potentially relevant to weight management